2022
DOI: 10.1186/s12876-022-02374-y
|View full text |Cite
|
Sign up to set email alerts
|

Validation of the new ABC score for predicting 30-day mortality in gastrointestinal bleeding

Abstract: Background/Aim The ABC score is a new pre-endoscopic scoring system that was recently developed to accurately predict one-month mortality in upper and lower gastrointestinal bleeding (GIB). We aim to validate this new score on a cohort of Lebanese patients treated in a tertiary care center and to compare it to currently existing scores. Methods Adult patients admitted to the American University of Beirut Medical Center (AUBMC) with overt GIB betwee… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 17 publications
(19 reference statements)
1
2
0
Order By: Relevance
“…On the contrary, early recognition of high-risk patients requiring urgent hospitalization and intervention prevents delays in treatment, thus reducing morbidity and mortality 15 . In the high-risk patient group of the ABC score, which has the highest AUC value in this study, the in-hospital mortality rate was 22.9%, which is consistent with the literature 10,16 ABC: age, blood tests, and comorbidities; AIMS65: albumin level <30 g/L (A), international normalized ratio >1.5 (I), altered mental status (M), systolic blood pressure ≤90 mmHg (S), and age >65 years (65); ASA: American Society of Anesthesiologists. CHAMPS: CCI ≥2, in-hospital onset, albumin <2.5 g/dL, altered mental status, ECOG-PS ≥2, steroids; CCI: Charlson Comorbidity Index; ECOG-PS: Eastern Cooperative Oncology Group Performance Status; INR: international normalized ratio; IQR: interquartile range; NSAIDs: nonsteroidal anti-inflammatory drugs, SD: standard deviation.…”
Section: Discussionsupporting
confidence: 91%
“…On the contrary, early recognition of high-risk patients requiring urgent hospitalization and intervention prevents delays in treatment, thus reducing morbidity and mortality 15 . In the high-risk patient group of the ABC score, which has the highest AUC value in this study, the in-hospital mortality rate was 22.9%, which is consistent with the literature 10,16 ABC: age, blood tests, and comorbidities; AIMS65: albumin level <30 g/L (A), international normalized ratio >1.5 (I), altered mental status (M), systolic blood pressure ≤90 mmHg (S), and age >65 years (65); ASA: American Society of Anesthesiologists. CHAMPS: CCI ≥2, in-hospital onset, albumin <2.5 g/dL, altered mental status, ECOG-PS ≥2, steroids; CCI: Charlson Comorbidity Index; ECOG-PS: Eastern Cooperative Oncology Group Performance Status; INR: international normalized ratio; IQR: interquartile range; NSAIDs: nonsteroidal anti-inflammatory drugs, SD: standard deviation.…”
Section: Discussionsupporting
confidence: 91%
“…For example, the average score in the study by Li Y. et al (2022) was 4.0 [24], Saade M.C. et al reported 5.26 [9], and Jimenez-Rosales R. et al (2023) reported 4.5 [25]. It is evident that the average ABC score in our study is significantly higher, and this difference may arise from the criteria for selecting patients to participate in this study.…”
Section: Discussionmentioning
confidence: 44%
“…Additionally, compared to other scoring systems like AIMS65, Rockall, and Glasgow-Blatchford, the ABC score demonstrated similar or significantly better predictive ability in predicting 30-day mortality and early recurrent hemorrhage rates in patients with gastrointestinal bleeding [6][7][8]. Following the study by Laursen S.B., several other studies have also reinforced the solid predictive value of the ABC score in predicting 30-day mortality in patients with upper gastrointestinal bleeding with an accurately predicted AUROC of approximately 0.85 [7,9,10]. However, there is currently a limitation of data available on the value of the ABC score in predicting healthcare facility mortality (typically within about a week) and early re-hemorrhage rates (within five days).…”
Section: Introductionmentioning
confidence: 79%
“…This is because the AIMS65 score was designed to be used with high cutoff values to identify patients at high risk for death rather than those at low risk for safe discharge, and about 20% of high-risk patients may be classified as being at low risk ( 2 ). In this study, the data value for albumin was missing in more than 20% of the total population; for comparison, we replaced the Charlson Comorbidity Index (CCI) value with the albumin level according to severity; following the previous literature, we replaced patients with a CCI equal to or greater than 5 points with albumin below 30 g/L ( 33 ). In our study, the AUC of AIMS65 for predicting GIB mortality was 0.776 and 0.802 in the training and validation groups, respectively.…”
Section: Discussionmentioning
confidence: 99%